Contact Us
Drug Search Results
More Filters [+]

Eugenol

Alternative Names: eugenol
Latest Update: 2024-11-13
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Voltage-Gated Sodium Channel Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Australia | Austria | Chile | China | Colombia | Cyprus | France | Germany | Greece | Hong Kong | India | Indonesia | Ireland | Italy | Lithuania | Malaysia | Morocco | Netherlands | Pakistan | Philippines | Slovenia | Spain | Sweden | Taiwan | Thailand | United Arab Emirates | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Colgate Palmolive
Company Location: NEW YORK NY 10022
Company CEO: Noel R. Wallace
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Eugenol

Countries in Clinic: Germany

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Dental Plaque

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CRO-2022-10-PG-MER-MW-JG

P3

Completed

Dental Plaque

2024-03-06

38%

Recent News Events

Date

Type

Title

08/28/2024

News Article

 Vanillin Market to Grow by USD 510.1 Million from 2024-2028, Driven by Rising Disposable Incomes and AI's Influence on Market Trends - Technavio Report

08/16/2024

News Article

 Dental Consumables Market Surges to USD 56.31 Billion by 2031, Propelled by 7% CAGR - Verified Market Research®

07/29/2024

News Article

 Penn Dental Medicine Researchers Leveraging Far-Flung Taste and Smell Sensors

05/15/2024

PubMed

 Effect of common horsetail extract on growth characteristics, essential oil yield and chemical compositions of basil (Ocimum basilicum L.).

05/15/2024

PubMed

 Synergistic anti-virulence efficacy of citral and carvacrol against mixed vaginitis causing Candida albicans and Gardnerella vaginalis: An in vitro and in vivo study.

05/01/2024

PubMed

 Enantioselective high-performance liquid chromatography combined with spectroscopic methods and theoretical calculations: A valid strategy to determine the absolute configuration of eugenol derivatives.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions